|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | The emerging role of probiotics in neurodegenerative diseases:new hope for Parkinson’s disease?显示文摘Neurodegenerative disease etiology is still unclear,but different contributing factors,such as lifestyle and genetic factors are involved.Altered components of the gut could play a key role in the gut-brain axis,which is a bidirectional system between the central nervous system and the enteric nervous system.Variations in the composition of the gut microbiota and its function between healthy people and patients have been reported for a variety of human disorders comprising metabolic,autoimmune,cancer,and,notably,neurodegenerative disorders.Diet can alter the microbiota composition,affecting the gutbrain axis function.Different nutraceutical interventions have been devoted to normalizing gut microbiome dysbiosis and to improving biological outcomes in neurological conditions,including the use of probiotics.Preclinical and clinical investigations discussed in this review strengthen the correlation between intestinal microbiota and brain and the concept that modifying the microbiome composition may improve brain neurochemistry,modulating different pathways.This review will discuss the potential use of probiotics for Parkinson’s disease prevention or treatment or as adjuvant therapy,confirming that gut microbiota modulation influences different pro-survival pathways.Future investigations in Parkinson’s disease should consider the role of the gut-brain axis and additional comprehension of the underlying mechanisms is extremely necessary. | Vanessa Castelli Michele d’Angelo Massimiliano Quintiliani Elisabetta Benedetti Maria Grazia Cifone Annamaria Cimini | 2021 | Neural Regeneration Research2021，16，4： | 2 |
| 2 | Economic impact of streamlining antibiotic administration显示文摘 | Quintiliani R Cooper BW Briceland LL | 1987 | Am J Med1987，82，4： | 1 |
| 3 | Economic impact of streamslining antibiotic administration 显示文摘 | Quintiliani R Cooper BW Briceland LL | 1987 | Am J Med1987，82，4： | 1 |
| 4 | Economic impact of streamlining antibiotic administration 显示文摘 | Quintiliani R Cooper BW Briceland LL | 1987 | Am J Med1987，82，4： | 1 |
| 5 | Pseudomonas aeruginosa: antimicrobial resistance, pharmacodynamic concepts, and antibiotic therapy显示文摘 | Sun HY Fujitani S Quintiliani R | 2011 | Chest2011，139，5： | 1 |
| 6 | The vanB gene con- fers various levels of self-transferable resistance to vanco- myein in enterococci显示文摘 | Quintiliani R Evers S Courvalin P | 1993 | J Infect Dis1993，167，5： | 1 |
| 7 | Pneumonia due to Pseudo monas aeruginosa: part antimicrobial resistance, pharmacodynamic concept s, and antibiotic therapy显示文摘 | Sun HY Fujitani S Quintiliani R | 2011 | Chest2011，139，5： | 1 |
| 8 | The CroRS two component regulatory system is required for intrinsic beta-lactam resistance in Enterococcus faecalis显示文摘 | Comenge Y Quintiliani R Jr Li L | | 0，，24： | 1 |
| 9 | Differentiating carbapenems:imipenem/cilastatin and meropenem显示文摘 | Ambrose PG Quintiliani R Richardson MA | 1998 | Today''s Therapeutic Trends1998，16，： | 1 |
| 10 | Treatment of Serratia marcescens meningitis with prolonged infusion of meropenem显示文摘 | Nicasio AM Quintiliani R Jr DeRyke CA | 2007 | Ann Pharmacother2007，41，6： | 1 |
| 11 | Transitional(intrave-nous tooral) antibiotic therapy 显示文摘 | Quintiliani R Grant E Quintiliani R Jr | 2000 | Med Liban2000，48，4： | 1 |
| 12 | Role of glutathione in affecting the radiosensitivity of molecular and cellular systems显示文摘 | Simone G Tamba M Quintiliani M | 1983 | Radiat Environ Biophys1983，22，3： | 1 |
| 13 | Economic impact of streamslining antibiotic administration 显示文摘 | Quintiliani R Cooper BW Briceland LL | 1987 | Am J Med1987，82，4： | 1 |
| 14 | Treatment of Ser- ratia marcescens meningitis with prolonged infusion of meropenem 显示文摘 | Nicasio A M Quintiliani R Jr DeRyke C A | 2007 | Ann Pharmacother2007，41，6： | 1 |
| 15 | Antibiotic kinetics and dynamics for the clinician显示文摘 | Quintiliani R Nightingale CH | 1995 | Med Clin North Am1995，79，3： | 1 |
| 16 | Economic impact of streamslining antibiotic administration显示文摘 | Quintiliani R Cooper BW Briceland LL | 1987 | Am J med1987，82，4： | 1 |
| 17 | Regulation of VanA-and VanB- type glyeopeptide resistance in enteroeocci显示文摘 | Arhtur M Quintiliani R Jr | 2001 | Antimierob Agents Chemother2001，45，2： | 1 |
| 18 | Pharmacokinetics and pharmacodynamics of total and unbound cefoxitin and cefotetan in healthy volunteers显示文摘 | Carver PL Nightingale CH Quintiliani R | 1989 | J Antimicrob Chemother1989，23，1： | 1 |
| 19 | Pneumonia due to Pseudomonas aeruginosa:part Ⅱ:antimicrobial resistance,pharmacodynamic concepts,and antibiotic therapy显示文摘 | Sun H Fujitani S Quintiliani R | | 0，，05： | 1 |
| 20 | Cost -effectiveness of ceftazidime by continuous infusion versus intermit tent infusion for nosocomial pneumonia显示文摘 | McNabb JJ Nightingale CH Quintiliani R | 2001 | Pharmacotherapy2001，21，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员